• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 CRUST 进行多区域测序追踪非整倍体癌症的进化。

Tracing the evolution of aneuploid cancers by multiregional sequencing with CRUST.

机构信息

Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.

Department of Pediatrics, Skåne University Hospital, Lund, Sweden.

出版信息

Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab292.

DOI:10.1093/bib/bbab292
PMID:34343239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8981300/
Abstract

Clonal deconvolution of mutational landscapes is crucial to understand the evolutionary dynamics of cancer. Two limiting factors for clonal deconvolution that have remained unresolved are variation in purity and chromosomal copy number across different samples of the same tumor. We developed a semi-supervised algorithm that tracks variant calls through multi-sample spatiotemporal tumor data. While normalizing allele frequencies based on purity, it also adjusts for copy number changes at clonal deconvolution. Absent à priori copy number data, it renders in silico copy number estimations from bulk sequences. Using published and simulated tumor sequences, we reliably segregated clonal/subclonal variants even at a low sequencing depth (~50×). Given at least one pure tumor sample (>70% purity), we could normalize and deconvolve paired samples down to a purity of 40%. This renders a reliable clonal reconstruction well adapted to multi-regionally sampled solid tumors, which are often aneuploid and contaminated by non-cancer cells.

摘要

克隆去卷积对于理解癌症的进化动态至关重要。克隆去卷积的两个限制因素仍然没有得到解决,即同一肿瘤的不同样本的纯度和染色体拷贝数存在差异。我们开发了一种半监督算法,可以通过多样本时空肿瘤数据跟踪变异调用。在根据纯度归一化等位基因频率的同时,它还调整了克隆去卷积时的拷贝数变化。在没有先验拷贝数数据的情况下,它可以从批量序列中生成虚拟拷贝数估计值。使用已发表和模拟的肿瘤序列,即使在低测序深度(约 50×)下,我们也可以可靠地分离克隆/亚克隆变体。只要有一个纯肿瘤样本(>70%的纯度),我们就可以将配对样本归一化和去卷积到 40%的纯度。这可以进行可靠的克隆重建,非常适合多区域采样的实体瘤,这些肿瘤通常是非整倍体的,并且被非癌细胞污染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/dee934a69e0a/bbab292f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/d170e77a48ac/bbab292f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/25d5b32476d2/bbab292f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/560d39fc08fa/bbab292f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/a75861605d37/bbab292f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/dee934a69e0a/bbab292f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/d170e77a48ac/bbab292f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/25d5b32476d2/bbab292f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/560d39fc08fa/bbab292f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/a75861605d37/bbab292f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a3d/8981300/dee934a69e0a/bbab292f5.jpg

相似文献

1
Tracing the evolution of aneuploid cancers by multiregional sequencing with CRUST.利用 CRUST 进行多区域测序追踪非整倍体癌症的进化。
Brief Bioinform. 2021 Nov 5;22(6). doi: 10.1093/bib/bbab292.
2
CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.CLImAT-HET:从全基因组测序数据中检测异质性肿瘤样本中的亚克隆拷贝数改变和杂合性缺失
BMC Med Genomics. 2017 Mar 15;10(1):15. doi: 10.1186/s12920-017-0255-4.
3
CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data.CloneCNA:从全外显子测序数据中检测异质性肿瘤样本中的亚克隆体细胞拷贝数改变。
BMC Bioinformatics. 2016 Aug 19;17:310. doi: 10.1186/s12859-016-1174-7.
4
DEVOLUTION-A method for phylogenetic reconstruction of aneuploid cancers based on multiregional genotyping data.基于多区域基因分型数据的非整倍体癌症系统发生重建的一种方法。
Commun Biol. 2021 Sep 20;4(1):1103. doi: 10.1038/s42003-021-02637-6.
5
QuantumClone: clonal assessment of functional mutations in cancer based on a genotype-aware method for clonal reconstruction.QuantumClone:基于基因型感知克隆重建方法的癌症功能突变的克隆评估。
Bioinformatics. 2018 Jun 1;34(11):1808-1816. doi: 10.1093/bioinformatics/bty016.
6
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing data.利用单核苷酸多态性(SNP)阵列和测序数据解析非整倍体乳腺肿瘤中的克隆性
Genome Biol. 2014 Oct 1;15(9):470. doi: 10.1186/s13059-014-0470-7.
7
Tumor Copy Number Deconvolution Integrating Bulk and Single-Cell Sequencing Data.肿瘤拷贝数去卷积整合批量和单细胞测序数据。
J Comput Biol. 2020 Apr;27(4):565-598. doi: 10.1089/cmb.2019.0302. Epub 2020 Mar 16.
8
Clonality Inference from Single Tumor Samples Using Low-Coverage Sequence Data.利用低覆盖度序列数据从单一肿瘤样本推断克隆性
J Comput Biol. 2017 Jun;24(6):515-523. doi: 10.1089/cmb.2016.0148. Epub 2017 Jan 5.
9
Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers.广泛的克隆分支塑造了高危儿科癌症的进化史。
Cancer Res. 2020 Apr 1;80(7):1512-1523. doi: 10.1158/0008-5472.CAN-19-3468. Epub 2020 Feb 10.
10
PhyloWGS: reconstructing subclonal composition and evolution from whole-genome sequencing of tumors.PhyloWGS:从肿瘤全基因组测序中重建亚克隆组成与进化
Genome Biol. 2015 Feb 13;16(1):35. doi: 10.1186/s13059-015-0602-8.

引用本文的文献

1
DEVOLUTION-A method for phylogenetic reconstruction of aneuploid cancers based on multiregional genotyping data.基于多区域基因分型数据的非整倍体癌症系统发生重建的一种方法。
Commun Biol. 2021 Sep 20;4(1):1103. doi: 10.1038/s42003-021-02637-6.

本文引用的文献

1
Subclonal reconstruction of tumors by using machine learning and population genetics.利用机器学习和群体遗传学进行肿瘤亚克隆重建。
Nat Genet. 2020 Sep;52(9):898-907. doi: 10.1038/s41588-020-0675-5. Epub 2020 Sep 2.
2
A dynamic mutational landscape associated with an inter-regionally diverse immune response in malignant rhabdoid tumour.恶性横纹肌样瘤中与区域性免疫反应多样化相关的动态突变景观。
J Pathol. 2020 Sep;252(1):22-28. doi: 10.1002/path.5490. Epub 2020 Jul 22.
3
Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers.
广泛的克隆分支塑造了高危儿科癌症的进化史。
Cancer Res. 2020 Apr 1;80(7):1512-1523. doi: 10.1158/0008-5472.CAN-19-3468. Epub 2020 Feb 10.
4
The evolutionary history of 2,658 cancers.2658 种癌症的进化史。
Nature. 2020 Feb;578(7793):122-128. doi: 10.1038/s41586-019-1907-7. Epub 2020 Feb 6.
5
Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR-ANXA2, EGFR-RAD51, ATR and BRCA2 mutations: A case report.化疗联合贝伐珠单抗治疗携带 EGFR-ANXA2、EGFR-RAD51、ATR 和 BRCA2 突变的晚期肺腺癌:一例报告。
Thorac Cancer. 2020 Feb;11(2):456-460. doi: 10.1111/1759-7714.13286. Epub 2019 Dec 22.
6
The genomic landscape of nonsmall cell lung carcinoma in never smokers.从不吸烟者的非小细胞肺癌的基因组景观。
Int J Cancer. 2020 Jun 1;146(11):3207-3218. doi: 10.1002/ijc.32797. Epub 2019 Dec 10.
7
NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.NOVA1 将 PTBP1 导向 hTERT 前体 mRNA,并促进癌细胞中的端粒酶活性。
Oncogene. 2019 Apr;38(16):2937-2952. doi: 10.1038/s41388-018-0639-8. Epub 2018 Dec 19.
8
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer.四种进化轨迹是儿童癌症肿瘤内遗传变异的基础。
Nat Genet. 2018 Jul;50(7):944-950. doi: 10.1038/s41588-018-0131-y. Epub 2018 Jun 4.
9
Quantification of subclonal selection in cancer from bulk sequencing data.从 bulk 测序数据中定量癌症中的亚克隆选择。
Nat Genet. 2018 Jun;50(6):895-903. doi: 10.1038/s41588-018-0128-6. Epub 2018 May 28.
10
Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.- 突变与 PD-1 抑制剂耐药在 - 突变型肺腺癌中的研究进展
Cancer Discov. 2018 Jul;8(7):822-835. doi: 10.1158/2159-8290.CD-18-0099. Epub 2018 May 17.